Corporate News     10-Mar-23
Natco Pharma launches additional strengths for lenalidomide capsules in U.S.
Natco Pharma announced the launch of additional strengths for the generic version of Revlimid® (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries.

With this launch the companies made available all the strengths of lenalidomide in the US market. Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma

Previous News
  Natco Pharma Ltd up for third straight session
 ( Hot Pursuit - 25-Jan-24   13:06 )
  Natco Pharma consolidated net profit rises 40.07% in the March 2024 quarter
 ( Results - Announcements 28-May-24   12:05 )
  Natco Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 26-Jun-23   13:05 )
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 09-Aug-22   18:51 )
  US Appeals Court rejects Alvogen's appeal on Ibrutinib Tablets
 ( Corporate News - 16-Nov-22   09:47 )
  Natco Pharma reports consolidated net profit of Rs 275.80 crore in the March 2023 quarter
 ( Results - Announcements 29-May-23   15:39 )
  Natco Pharma receives USFDA approval for Carfilzomib Vials ANDA
 ( Corporate News - 14-Jun-21   12:56 )
  Natco Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Natco Pharma fixes record date for payment of interim dividend
 ( Market Beat - Reports 12-Feb-20   18:41 )
  Natco Pharma clears USFDA inspection of its Pharmacovigilance compliance
 ( Corporate News - 02-Nov-23   09:05 )
  Natco Pharma
 ( Results - Analysis 30-May-23   11:27 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top